Back to search

Article

The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice

2023-06-08

Abstract excerpt

<h4>Background: </h4> Cardiac steatosis is an early yet overlooked feature of diabetic cardiomyopathy. There is no available therapy to treat this condition. Tyrosine kinase inhibitors (TKIs), clinically used as an anti-cancer treatment, influence glucose and lipid metabolism, leading to improved glycemic control and allowing insulin discontinuation in cancer patients with diabetes mellitus. The present study aime...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4c0855ba-2547-517f-804a-6a2dc1213659
DOI
10.21203/rs.3.rs-3024470/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic miceDOI 10.21203/rs.3.rs-3024470/v1
Select a neighboring publication to make it the new centre.